“We’re excited to share this promising data from Synedgen’s ophthalmic glycopolymer candidates, given the lack of effective drugs for this type of damage to the eye,” said Dr. Brian Gilger, study lead ...
Global healthcare company Grifols has partnered with BARDA, the Biomedical Advanced Research and Development Authority, to develop the first immune therapy eye drops to prevent the long-term effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results